Agilent Technologies (A) 47.18 $A
Agilent Technologies Announces Availability of New Companion Diagnostic in Europe
BusinessWire - Wed Aug 03, 2:01AM CDT
Dako, Agilent Pathology Solutions, a worldwide leader in partnering with pharmaceutical companies to develop immunohistochemical-based diagnostics for cancer therapy, today announced the CE Mark certification for use of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer (NSCLC) is likely to respond to KEYTRUDA(R) (pembrolizumab), an anti-PD-1 therapy manufactured by Merck & Co., Inc., Kenilworth, N.J., USA (known as MSD outside the U.S. and Canada).
A: 47.18 (-0.69)
Agilent Technologies Completes Asset Acquisition of iLab Solutions, a Leader in Cloud-Based Laboratory Management Software
BusinessWire - Mon Aug 01, 3:05PM CDT
Agilent Technologies Inc. (NYSE: A) today announced it has completed the asset acquisition of iLab Solutions LLC, a leader in cloud-based solutions for core laboratory management.
A: 47.18 (-0.69)
Agilent Technologies to Host Webcast of Third-Quarter Fiscal Year 2016 Financial Results Conference Call
BusinessWire - Fri Jul 29, 10:00AM CDT
Agilent Technologies Inc. (NYSE:A) will release third-quarter fiscal 2016 financial results after the stock market closes on Aug. 17. The company will host a live webcast of its investor conference call in listen-only mode.
A: 47.18 (-0.69)
Agilent Technologies Array CGH Platform Assures Quality of Cancer Cell Lines Used in Biomedical Research
BusinessWire - Thu Jul 28, 10:00AM CDT
Agilent Technologies Inc. (NYSE:A) today announced that scientists using the company's comparative genomic hybridization (CGH) technology have shown that cancer cell lines, which are broadly used in all aspects of biomedical research, may have vast differences in their genetic makeup, even when grown in the same batch.
A: 47.18 (-0.69)
Itron (ITRI) Settles Patent Litigation Claims of TransData
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 5:41PM CDT
Itron (ITRI) has reached an agreement to settle patent litigation claims brought by TransData.
AMKR: 7.30 (+0.85), ITRI: 42.65 (-0.63), A: 47.18 (-0.69), CGNX: 48.94 (+3.62)
Global Spectroscopy Equipment Market Worth USD 15.6 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: ABB Analytical, Agilent Technologies, TSJ - Research and Markets
BusinessWire - Fri Jun 24, 9:24AM CDT
Research and Markets has announced the addition of the "Global Markets for Spectroscopy Equipment" report to their offering.
A: 47.18 (-0.69)
Itron Smart Water Solution to Improve PWC's Water Delivery
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 5:07PM CDT
Itron's (ITRI) smart water solution has been selected by PWC to improve water delivery.
SCON: 2.65 (-0.25), ITRI: 42.65 (-0.63), A: 47.18 (-0.69), CGNX: 48.94 (+3.62)
Global Biomarkers Market Worth USD 92.5 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Agilent Technologies, Bio-Rad Labs - Research and Markets
BusinessWire - Fri Jun 17, 3:01PM CDT
Research and Markets has announced the addition of the "Global Biomarkers Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 45.07 (-0.22), A: 47.18 (-0.69)
Itron, WaterSmart Tie Up to Boost Water Efficiency in Utilities
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:22AM CDT
Itron (ITRI) has entered into a new alliance with WaterSmart Software to offer consumer engagement platform.
ITRI: 42.65 (-0.63), COMM: 28.66 (-0.93), A: 47.18 (-0.69), CGNX: 48.94 (+3.62)
Protein Electrophoresis & Western Analysis Life Science Dashboard Series 3 (NA & EU) - Analysis, Technologies & Forecasts - Key Vendors: Abnova, Agilent Technologies, Biomatik - Research and Markets
BusinessWire - Wed Jun 15, 4:21AM CDT
Research and Markets has announced the addition of the "Protein Electrophoresis and Western Analysis Life Science Dashboard Series 3 (NA & EU)" report to their offering.
A: 47.18 (-0.69)
Global Biochip Industry
PR Newswire - Tue Jun 07, 5:40PM CDT
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -
A: 47.18 (-0.69), AFFX: 14.01 (+0.02)
Itron (ITRI) Scales New 52-Week High on Healthy Prospects
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:09AM CDT
On Jun 6, 2016, shares of Itron, Inc. (ITRI) scaled a new 52-week high of $45.20.
ITRI: 42.65 (-0.63), A: 47.18 (-0.69), CGNX: 48.94 (+3.62), ADTN: 17.81 (-0.28)
20.7% Return Seen to Date on SmarTrend Agilent Technologies Call (A)
Comtex SmarTrend(R) - Tue Jun 07, 1:12AM CDT
SmarTrend identified an Uptrend for Agilent Technologies (NYSE:A) on February 22nd, 2016 at $37.99. In approximately 4 months, Agilent Technologies has returned 20.73% as of today's recent price of $45.86.
A: 47.18 (-0.69)
Agilent Technologies Launches New Solutions for Pharma, Biopharma, Metabolomics and Environmental Researchers Across Mass Spec Portfolio
BusinessWire - Mon Jun 06, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today introduced a wide range of systems, software and technologies designed to improve both the speed and accuracy of mass spectrometry.
A: 47.18 (-0.69)
Agilent Technologies to Present at Goldman Sachs 37th Annual Global Healthcare Conference and Jefferies 2016 Healthcare Conference
BusinessWire - Wed Jun 01, 10:00AM CDT
Agilent Technologies Inc. (NYSE:A) today announced the following webcasts for the investment community:
A: 47.18 (-0.69)
Itron Hits 52-Week High on Upbeat Preliminary Q1 Results
Zacks Equity Research - Zacks Investment Research - Wed May 25, 9:57AM CDT
On May 24, 2016, shares of Itron, Inc. (ITRI) scaled a new 52-week high of $43.61, before closing a notch lower at $43.50.
ITRI: 42.65 (-0.63), A: 47.18 (-0.69), CGNX: 48.94 (+3.62), ADTN: 17.81 (-0.28)
Itron Upgraded to Buy: Time to Add the Stock to Your Portfolio
Zacks Equity Research - Zacks Investment Research - Thu May 19, 7:03AM CDT
On May 19, 2016, Zacks Investment Research upgraded Itron, Inc. (ITRI) to a Zacks Rank #2 (Buy).
ITRI: 42.65 (-0.63), A: 47.18 (-0.69), FN: 35.02 (-3.01), ROG: 66.55 (-1.42)
Agilent Technologies Announces Cash Dividend of 11.5 Cents per Share
BusinessWire - Wed May 18, 3:05PM CDT
Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 11.5 cents per share of common stock will be paid on July 27, 2016, to all shareholders of record as of the close of business on July 5, 2016.
A: 47.18 (-0.69)
Research and Markets - Global Particle Size Analysis Market Worth USD 256.1 Million by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Agilent Technologies, IZON Science Limited, Microtrac
PR Newswire Europe - Wed May 18, 1:11PM CDT
DUBLIN, May 18, 2016 /PRNewswire/ --
A: 47.18 (-0.69)
Agilent Technologies Announces Availability of New Companion Diagnostic in Europe
BusinessWire - Wed Aug 03, 2:01AM CDT
Dako, Agilent Pathology Solutions, a worldwide leader in partnering with pharmaceutical companies to develop immunohistochemical-based diagnostics for cancer therapy, today announced the CE Mark certification for use of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer (NSCLC) is likely to respond to KEYTRUDA(R) (pembrolizumab), an anti-PD-1 therapy manufactured by Merck & Co., Inc., Kenilworth, N.J., USA (known as MSD outside the U.S. and Canada).
A: 47.18 (-0.69)
Agilent Technologies Completes Asset Acquisition of iLab Solutions, a Leader in Cloud-Based Laboratory Management Software
BusinessWire - Mon Aug 01, 3:05PM CDT
Agilent Technologies Inc. (NYSE: A) today announced it has completed the asset acquisition of iLab Solutions LLC, a leader in cloud-based solutions for core laboratory management.
A: 47.18 (-0.69)
Agilent Technologies to Host Webcast of Third-Quarter Fiscal Year 2016 Financial Results Conference Call
BusinessWire - Fri Jul 29, 10:00AM CDT
Agilent Technologies Inc. (NYSE:A) will release third-quarter fiscal 2016 financial results after the stock market closes on Aug. 17. The company will host a live webcast of its investor conference call in listen-only mode.
A: 47.18 (-0.69)
Agilent Technologies Array CGH Platform Assures Quality of Cancer Cell Lines Used in Biomedical Research
BusinessWire - Thu Jul 28, 10:00AM CDT
Agilent Technologies Inc. (NYSE:A) today announced that scientists using the company's comparative genomic hybridization (CGH) technology have shown that cancer cell lines, which are broadly used in all aspects of biomedical research, may have vast differences in their genetic makeup, even when grown in the same batch.
A: 47.18 (-0.69)
Itron (ITRI) Settles Patent Litigation Claims of TransData
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 5:41PM CDT
Itron (ITRI) has reached an agreement to settle patent litigation claims brought by TransData.
AMKR: 7.30 (+0.85), ITRI: 42.65 (-0.63), A: 47.18 (-0.69), CGNX: 48.94 (+3.62)
Global Spectroscopy Equipment Market Worth USD 15.6 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: ABB Analytical, Agilent Technologies, TSJ - Research and Markets
BusinessWire - Fri Jun 24, 9:24AM CDT
Research and Markets has announced the addition of the "Global Markets for Spectroscopy Equipment" report to their offering.
A: 47.18 (-0.69)
Itron Smart Water Solution to Improve PWC's Water Delivery
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 5:07PM CDT
Itron's (ITRI) smart water solution has been selected by PWC to improve water delivery.
SCON: 2.65 (-0.25), ITRI: 42.65 (-0.63), A: 47.18 (-0.69), CGNX: 48.94 (+3.62)
Global Biomarkers Market Worth USD 92.5 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Agilent Technologies, Bio-Rad Labs - Research and Markets
BusinessWire - Fri Jun 17, 3:01PM CDT
Research and Markets has announced the addition of the "Global Biomarkers Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 45.07 (-0.22), A: 47.18 (-0.69)
Itron, WaterSmart Tie Up to Boost Water Efficiency in Utilities
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:22AM CDT
Itron (ITRI) has entered into a new alliance with WaterSmart Software to offer consumer engagement platform.
ITRI: 42.65 (-0.63), COMM: 28.66 (-0.93), A: 47.18 (-0.69), CGNX: 48.94 (+3.62)
Protein Electrophoresis & Western Analysis Life Science Dashboard Series 3 (NA & EU) - Analysis, Technologies & Forecasts - Key Vendors: Abnova, Agilent Technologies, Biomatik - Research and Markets
BusinessWire - Wed Jun 15, 4:21AM CDT
Research and Markets has announced the addition of the "Protein Electrophoresis and Western Analysis Life Science Dashboard Series 3 (NA & EU)" report to their offering.
A: 47.18 (-0.69)
Global Biochip Industry
PR Newswire - Tue Jun 07, 5:40PM CDT
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -
A: 47.18 (-0.69), AFFX: 14.01 (+0.02)
Itron (ITRI) Scales New 52-Week High on Healthy Prospects
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:09AM CDT
On Jun 6, 2016, shares of Itron, Inc. (ITRI) scaled a new 52-week high of $45.20.
ITRI: 42.65 (-0.63), A: 47.18 (-0.69), CGNX: 48.94 (+3.62), ADTN: 17.81 (-0.28)
20.7% Return Seen to Date on SmarTrend Agilent Technologies Call (A)
Comtex SmarTrend(R) - Tue Jun 07, 1:12AM CDT
SmarTrend identified an Uptrend for Agilent Technologies (NYSE:A) on February 22nd, 2016 at $37.99. In approximately 4 months, Agilent Technologies has returned 20.73% as of today's recent price of $45.86.
A: 47.18 (-0.69)
Agilent Technologies Launches New Solutions for Pharma, Biopharma, Metabolomics and Environmental Researchers Across Mass Spec Portfolio
BusinessWire - Mon Jun 06, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today introduced a wide range of systems, software and technologies designed to improve both the speed and accuracy of mass spectrometry.
A: 47.18 (-0.69)
Agilent Technologies to Present at Goldman Sachs 37th Annual Global Healthcare Conference and Jefferies 2016 Healthcare Conference
BusinessWire - Wed Jun 01, 10:00AM CDT
Agilent Technologies Inc. (NYSE:A) today announced the following webcasts for the investment community:
A: 47.18 (-0.69)
Itron Hits 52-Week High on Upbeat Preliminary Q1 Results
Zacks Equity Research - Zacks Investment Research - Wed May 25, 9:57AM CDT
On May 24, 2016, shares of Itron, Inc. (ITRI) scaled a new 52-week high of $43.61, before closing a notch lower at $43.50.
ITRI: 42.65 (-0.63), A: 47.18 (-0.69), CGNX: 48.94 (+3.62), ADTN: 17.81 (-0.28)
Itron Upgraded to Buy: Time to Add the Stock to Your Portfolio
Zacks Equity Research - Zacks Investment Research - Thu May 19, 7:03AM CDT
On May 19, 2016, Zacks Investment Research upgraded Itron, Inc. (ITRI) to a Zacks Rank #2 (Buy).
ITRI: 42.65 (-0.63), A: 47.18 (-0.69), FN: 35.02 (-3.01), ROG: 66.55 (-1.42)
Agilent Technologies Announces Cash Dividend of 11.5 Cents per Share
BusinessWire - Wed May 18, 3:05PM CDT
Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 11.5 cents per share of common stock will be paid on July 27, 2016, to all shareholders of record as of the close of business on July 5, 2016.
A: 47.18 (-0.69)
Research and Markets - Global Particle Size Analysis Market Worth USD 256.1 Million by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Agilent Technologies, IZON Science Limited, Microtrac
PR Newswire Europe - Wed May 18, 1:11PM CDT
DUBLIN, May 18, 2016 /PRNewswire/ --
A: 47.18 (-0.69)
